Holzer Holzer & Fistel, LLC Announces That It Has Filed a Class Action Lawsuit on Behalf of Investors in Questcor Pharmaceuticals, Inc.; Reminds Investors With Large Losses of Approaching Lead Plaintiff Deadline
(firmenpresse) - ATLANTA, GA -- (Marketwire) -- 10/03/12 -- Holzer Holzer & Fistel, LLC has filed a class action lawsuit in the United States District Court for the Central District of California on behalf of purchasers of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (NASDAQ: QCOR) common stock who purchased shares between April 26, 2011 and September 21, 2012, inclusive (the "Class Period"). The lawsuit alleges, among other things, that Questcor knew but failed to adequately disclose: a) the Company lacked clinical evidence to support the use of Acthar for indications other than infantile spasms; b) that Questcor engaged in questionable tactics to promote the sales and use of Acthar in the treatment of MS and nephrotic syndrome; and c) as a result, the Company lacked a reasonable basis to make positive statements about the Company or its outlook, including statements about the effectiveness of and potential market growth for Acthar.
If you purchased QCOR common stock during the Class Period, you have the legal right to petition the Court to be appointed a "lead plaintiff." A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. Any such request must satisfy certain criteria and be made no later than November 26, 2012. Any member of the purported class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. If you are a Questcor investor and would like to discuss a potential lead plaintiff appointment, or your rights and interests with respect to the lawsuit, you may contact Michael I. Fistel, Jr., Esq., or Marshall P. Dees, Esq. via email at , or , or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, and upon request from the firm.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.10.2012 - 09:02 Uhr
Sprache: Deutsch
News-ID 1156994
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
ATLANTA, GA
Phone:
Kategorie:
Legal
Anmerkungen:
Diese Pressemitteilung wurde bisher 151 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Holzer Holzer & Fistel, LLC Announces That It Has Filed a Class Action Lawsuit on Behalf of Investors in Questcor Pharmaceuticals, Inc.; Reminds Investors With Large Losses of Approaching Lead Plaintiff Deadline
"
steht unter der journalistisch-redaktionellen Verantwortung von
Holzer Holzer & Fistel, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
